glioblastoma
Researchers narrowed in on dual-treatment targets using expression and regulatory programs found in glioblastoma cells in and around the tumor.
Cure51 Partners With Cambridge University Hospitals, Others to Expand Cancer Survival Study to UK
Eight NHS cancer centers will examine tumors from patients with exceptional survival times, focusing on three aggressive cancer types.
Tango Therapeutics Ends Development of PRMT5 Inhibitor in Favor of Two Others
Based on early Phase I/II trial data, Tango has decided to end enrollment in a study of TNG908 and focus resources on more promising drugs in its pipeline.
Cancer Research UK, Minderoo Foundation Commit £3.4M to Fund Glioblastoma Platform Trial
The adaptive platform trial will perform whole-genome sequencing on every patient and test the activity of biomarker-guided treatments.
IN8bio to Lay off Nearly Half of Workforce, Narrow Pipeline Focus on AML Cell Therapy
The firm is dropping two glioblastoma programs and cutting 49 percent of its staff to advance its gamma delta T-cell therapy INB-100 in post-transplant AML.
Jul 24, 2024
May 13, 2024
Cancer Cell Therapies at ASGCT24
Dec 19, 2023
Sep 20, 2023
Mar 30, 2023
Nov 22, 2022